Key Takeaways
- • Navam Capital closed its inaugural Navam Venture Fund-I (NVF-I) at INR 315 crore (approximately USD 35 million), exceeding its initial INR 250 crore target through an oversubscribed green shoe option.
- • The Category II alternative investment fund has already deployed capital across eight portfolio companies and plans to invest in 15–16 companies total, focusing on deep-tech startups built in India for global markets.
- • Portfolio companies include Agnikul Cosmos, Ather Energy, Morphing Machines, and Unbox Robotics, with the latter recently securing USD 28 million in external funding.
- • Investment themes span advanced computing, semiconductors, robotics, drone technology, space technology, industrial automation, enterprise AI, climate technology, and materials science, with typical first cheques of INR 5–8 crore at seed and pre-Series A stages.
- • Limited partners include technology founders, industrial groups, business operators, conglomerates, and family offices, reflecting a diversified institutional and high-net-worth investor base.
Summary
The fund has already deployed capital into eight portfolio companies and commits to backing 15–16 companies in total. Notable portfolio holdings include space technology firm Agnikul Cosmos, electric two-wheeler manufacturer Ather Energy, robotics automation company Morphing Machines, and logistics robotics platform Unbox Robotics. Unbox Robotics recently raised USD 28 million in external funding, underscoring the quality of Navam's portfolio selection. The fund's investment thesis focuses on frontier technologies and science-driven innovation across advanced computing, semiconductors, robotics, drone technology, space technology, industrial automation, enterprise artificial intelligence, climate technology, and materials science.
Navam Capital's investment strategy emphasizes early-stage participation, with typical first cheques ranging from INR 5–8 crore at the seed and pre-Series A stages, while reserving dry powder for follow-on rounds and selective Series A and Series B investments. The fund has attracted a diversified limited partner base comprising technology founders, industrial groups, business operators, conglomerates, and family offices. Prior to founding Navam Capital, founder Rajeev Mantri spent formative years at New York-based venture capital firm Lux Capital, where he specialized in climate technology, biotechnology, and advanced materials. Mantri is also a co-founder of biopharma venture Vyome Therapeutics.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.